In 2023, there were significant advancements in trials of interventions to reduce mortality and morbidity from alcohol-related liver disease, spanning the entire spectrum of disease: primary prevention to reduce overall alcohol-related harm, secondary prevention to attenuate fibrosis progression and tertiary prevention using antibiotics for severe alcohol-associated hepatitis.

中文翻译：

---

针对酒精相关肝病的新干预措施

2023 年，旨在降低酒精相关性肝病死亡率和发病率的干预措施试验取得了重大进展，涵盖了整个疾病谱：减少酒精相关总体危害的一级预防、减缓纤维化进展的二级预防以及利用药物进行三级预防。抗生素治疗严重的酒精相关性肝炎。